| gptkbp:instanceOf | gptkb:drug 
 | 
                        
                            
                                | gptkbp:ATCCode | gptkb:N05BA 
 | 
                        
                            
                                | gptkbp:broadcastOn | gptkb:controlled_substance 
 | 
                        
                            
                                | gptkbp:category | gptkb:sedative gptkb:muscle_relaxant
 gptkb:benzodiazepine
 gptkb:hypnotic
 gptkb:anticonvulsant
 
 | 
                        
                            
                                | gptkbp:cause | tolerance withdrawal symptoms
 falls in elderly
 paradoxical reactions
 psychomotor impairment
 
 | 
                        
                            
                                | gptkbp:chemicalFormula | fusion of benzene and diazepine rings 
 | 
                        
                            
                                | gptkbp:contraindication | pregnancy history of substance abuse
 
 | 
                        
                            
                                | gptkbp:discoveredBy | gptkb:Leo_Sternbach 
 | 
                        
                            
                                | gptkbp:example | gptkb:lorazepam gptkb:clonazepam
 gptkb:diazepam
 gptkb:temazepam
 alprazolam
 
 | 
                        
                            
                                | gptkbp:excretion | kidneys 
 | 
                        
                            
                                | gptkbp:interactsWith | gptkb:beer opioids
 barbiturates
 
 | 
                        
                            
                                | gptkbp:legalStatus | prescription only 
 | 
                        
                            
                                | gptkbp:marketedAs | 1960 
 | 
                        
                            
                                | gptkbp:mechanismOfAction | enhance GABA-A receptor activity 
 | 
                        
                            
                                | gptkbp:metabolism | liver 
 | 
                        
                            
                                | gptkbp:overdoseTreatment | gptkb:flumazenil 
 | 
                        
                            
                                | gptkbp:riskFactor | addiction cognitive impairment
 overdose
 
 | 
                        
                            
                                | gptkbp:routeOfAdministration | oral intramuscular
 intravenous
 
 | 
                        
                            
                                | gptkbp:shouldNotBeCombinedWith | gptkb:CNS_depressants 
 | 
                        
                            
                                | gptkbp:sideEffect | confusion drowsiness
 respiratory depression
 dependence
 memory impairment
 
 | 
                        
                            
                                | gptkbp:usedFor | insomnia anxiety disorders
 seizure disorders
 muscle spasms
 alcohol withdrawal
 
 | 
                        
                            
                                | gptkbp:bfsParent | gptkb:GABA 
 | 
                        
                            
                                | gptkbp:bfsLayer | 5 
 | 
                        
                            
                                | https://www.w3.org/2000/01/rdf-schema#label | benzodiazepines 
 |